kamada.com - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi KMDA

Logo perusahaan publik Kamada (KMDA)

Kamada Ltd. enjoys global recognition in the therapy of orphan diseases, as confirmed by its current EBITDA. The value of 43.31 defines the current level of this metric. Growth is driven by the sale of plasma products and a contract with Takeda. Stability is ensured by a strict raw material transportation protocol utilizing specialized carriers, which eliminates disruptions in the supply of finished medications.

Bathi operasional EBITDA kamada.com (KMDA): kanggo periode 23.11.2025 - 10.11.2026

Ringkesan rincian data analitis Kamada (KMDA)

- nilai saham lan prakiraan konsensus rega:
Bagan bursa Kamada Pharma|KMDA - Target konsensus
- rincian nilai pasar emiten:
Biji pasar Kamada|KMDA - Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Aset Bersih saben Saham Kamada|KMDA - Kapitalisasi Buku|Rasio Kapitalisasi marang Nilai Buku kamada.com|KMDA - Gunggung Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Kamada Ltd.|KMDA - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas Kamada Ltd|KMDA - Gunggung utang perusahaan|Rasio utang marang aset resik Kamada|KMDA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Kamada|Rasio jangkoan perantara kamada.com
- rincian bathi lan kelipatan pasar:
KMDA - Bathi resik perusahaan|Bathi mangsa ngarep Kamada Ltd.|KMDA - Pangali P/E|Pangali Forward P/E kamada.com|KMDA - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Kamada|KMDA - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Kamada|KMDA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan kamada.com|KMDA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Kamada Ltd.
Ringkesan analitik perusahaan:Kamada Pharma
Produk merek kamada.com

Kamada Ltd. (KMDA) maintains a monopoly status in the plasmapheresis segment, and the high cost of orphan drugs ensures a stable inflow of liquidity. An analysis of cash operating profit before deductions allows for an assessment of the daily volume of actual funds from core operations excluding depreciation and taxes, confirming the business's fundamental stability and its ability to generate free cash flow.

Karo sapa Kamada Ltd. saingan

Pendapatan operasional sadurunge ngurangi amortisasi Vertex Corp (VRTX)|ALNY: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi INSM|UTHR: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi BioMarin Pharmaceutical Inc. (BMRN)|BBIO (BridgeBio Pharma Inc) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi BGM (BGM Group Corp)|Bathi operasional sadurunge ngurangi amortisasi COGT (Cogent Biosciences)|XERS (xerispharma.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Keros Therapeutics, Inc. KROS|ARCT (Arcturus Therapeutics Inc) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Eton Pharma - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi FULC (Fulcrum Corp)|ABEO: Bathi operasional EBITDA|Mereo BioPharma Group plc (MREO) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Protalix BioTherapeutics, Inc.|PLRX: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Applied Therapeutics (APLT)|Bathi operasional sadurunge ngurangi amortisasi Aileron Therapeutics RNTX|Bathi operasional EBITDA GELS (Gelteq)|Bathi operasional EBITDA Aytu BioPharma Inc AYTU|CMMB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SRXH - Bathi operasional EBITDA|PLRZ: Bathi operasional EBITDA|Aeterna Zentaris Inc. (AEZS) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Cyclo Therapeutics|Bathi operasional sadurunge ngurangi amortisasi Inozyme (INZY)|Bathi operasional EBITDA RPHM|Bathi operasional EBITDA COSCIENS Biopharma Inc (CSCI)